Indices of oxidative stress in Parkinson's disease, Alzheimer's disease and dementia with Lewy bodies

Journal of Neural Transmission, Supplement

Volumn , Issue 51, 1997, Pages 167-173

  Owen, A D ^a   Schapira, A H V ^b,c   Jenner, P ^a   Marsden, C D ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; IRON; MITOCHONDRIAL ENZYME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ALZHEIMER DISEASE; BRAIN MITOCHONDRION; CONFERENCE PAPER; DEMENTIA; ENZYME ACTIVITY; HUMAN; IRON METABOLISM; LEWY BODY; NERVE CELL NECROSIS; NEUROPATHOLOGY; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA; AGED; METABOLISM; PHYSIOLOGY; REVIEW;

AGED; ALZHEIMER DISEASE; DEMENTIA; HUMANS; LEWY BODIES; OXIDATIVE STRESS; PARKINSON DISEASE;

EID: 0031283221     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6846-2_14     Document Type: Conference Paper

References (22)

1. Dexter DT, Wells FR, Agid F, Agid Y, Lees AJ, Jenner P, Marsden CD (1987) Increased nigral iron content in post-mortem parkinsonian brain. Lancet ii: 219-220
2. Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P, Marsden CD (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 52: 381-389
3. Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD (1989) Increased nigral iron content and alterations in other metal ions occurring in the brain in Parkinson's disease. J Neurochem 52: 1830-1836
4. Dexter DT, Carayon A, Vidaillhet M, Ruberg M, Agid F, Agid Y, Lees AJ, Wells FR, Jenner P, Marsden CD (1990) Decreased ferritin levels in brain in Parkinson's disease. J Neurochem 55: 16-20
5. Dexter DT, Sian J, Jenner P, Marsden CD (1993) Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia. Adv Neurol 60: 273-281
6. Dexter DT, Sian J, Rose S, Hindmarsh JG, Mann VM, Cooper JM, Wells FR, Daniel S, Lees AJ, Schapira AHV, Jenner P, Marsden CD (1994) Indices of oxidative stress and mitochondrial function in individuals with incidental Levvy Body disease. Ann Neurol 35: 38-44
7. Jenner P (1994) Oxidative damage in neurodegenerative disease. Lancet 344: 796-798
8. Mann VM, Cooper JM, Daniel SE, Srai K, Jenner P, Marsden CD, Schapira AHV (1994) Complex I, iron and ferritin in Parkinson's disease substantia nigra. Ann Neurol 36: 876-881
9. Mastrogiacomo F, Bergeron C, Kish SJ (1993) Brain α-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. J Neurochem 61: 2007-2014
10. Mecocci P, MacGarvey U, Flint-Beal M (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 36: 747-751
11. Mizuno Y, Matsuda S, Yoshina H, Mori H, Hattori N (1994) An immunohistochemical study of α-ketoglutarate dehydrogenase complex in Parkinson's disease. Ann Neurol 35: 204-210
12. Palmer AM, Burns MA (1994) Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease. Brain Res 645: 338-342
13. Parker WD, Parks JK (1995) Cytochrome c oxidase in Alzheimer's disease brain: purification and characterization. Neurol 45: 482-486
14. Perry T, Godin DV, Hansen S (1982) Parkinson's disease: a disorder due to nigral glutathione deficiency. Neurosci Lett 33: 305-310
15. Perry E, McKeith I, Perry R (1996) Dementia with Lewy bodies: clinical, pathological and treatment issues. Cambridge University Press
16. Reiderer P, Sofic E, Rausch W-D, Schmidt B, Reynolds GP, Jellinger K, Youdim MB (1989) Transition metals, ferritin, glutathione and ascorbic acid in Parkinson's disease. J Neurochem 52: 381-389
17. Sanchezramos JR, Overvik E, Ames BN (1994) A marker of oxyradical-mediated DNA damage (8-hydroxy-2′deoxyguanosine) is increased in nigro-striatum of Parkinson's disease brain. Neurodegeneration 3: 197-204
18. Schapira AHV, Cooper JM, Dexter DT, Clark JB, Jenner P, Marsden CD (1990a) Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 54: 823-827
19. 1 reductase (complex I) deficiency in Parkinson's disease. J Neurochem 55: 2142-2145
20. Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, Jenner P, Marsden CD (1994) Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting the basal ganglia. Ann Neurol 36: 348-355
21. Sian J, Dexter DT, Lees AJ, Daniel S, Jenner P, Marsden CD (1994) Glutathione-related enzymes in brain in Parkinson's disease. Ann Neurol 36: 356-361
22. Sofic E, Reiderer P, Heinsen, Beckmann H, Reynolds GP, Hebenstreit G, Youdim MB (1988) Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm 74: 199-205